Whether that selectivity advantage holds at doses and durations used outside research settings remains unverified
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said
( JAMA Network Open , 2022) If youre considering taking Ozempic or semaglutide, be sure to contact your healthcare provider, who can determine whether the drug is right for you
What I will say is that the metabolic profile patients end up with after 12 weeks (better fasting glucose, lower A1c, better lipids, more lean mass relative to fat) maps closely to what longevity researchers consider markers of healthy aging
Tune in to learn if GLP-1 drugs could fit your health goalsor if a few diet and lifestyle tweaks are all you need